Personal CFO Solutions’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,696
| Closed | -$35.1K | – | 574 |
|
|
2023
Q4 | $35.1K | Sell |
1,696
-134
| -7% | -$2.77K | 0.01% | 510 |
|
|
2023
Q3 | $58.2K | Sell |
1,830
-1,000
| -35% | -$31.8K | 0.01% | 450 |
|
|
2023
Q2 | $95.1K | Hold |
2,830
| – | – | 0.02% | 461 |
|
|
2023
Q1 | $118K | Hold |
2,830
| – | – | 0.02% | 459 |
|
|
2022
Q4 | $95.9K | Sell |
2,830
-33
| -1% | -$1.12K | 0.02% | 444 |
|
|
2022
Q3 | $141K | Buy |
2,863
+500
| +21% | +$24.6K | 0.04% | 394 |
|
|
2022
Q2 | $93K | Sell |
2,363
-133
| -5% | -$5.23K | 0.02% | 413 |
|
|
2022
Q1 | $92K | Buy |
2,496
+650
| +35% | +$24K | 0.02% | 452 |
|
|
2021
Q4 | $181K | Buy |
1,846
+401
| +28% | +$39.3K | 0.03% | 454 |
|
|
2021
Q3 | $180K | Buy |
1,445
+476
| +49% | +$59.3K | 0.04% | 425 |
|
|
2021
Q2 | $122K | Buy |
+969
| New | +$122K | 0.03% | 420 |
|